Platinum-based chemotherapy in triple-negative breast cancer. (Q46358330)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Platinum-based chemotherapy in triple-negative breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

B Sirohi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M Arnedos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Ashley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Nerurkar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

G Walsh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Johnston

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

I E Smith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

20 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1847-1852

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18567607%20AND%20SRC:MED&resulttype=core&format=json

'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

Hallmarks of 'BRCAness' in sporadic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

Cisplatin and its analogues in the treatment of advanced breast cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN395